title: Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration.
authors.affiliation: Division of Thoracic Diseases, Chiba Cancer Center, Chiba, Japan. nakajii@fc.med.miyazaki-u.ac.jp
authors.forename: Takahiro
authors.initials: T
authors.lastname: Nakajima
authors.forename: Hideki
authors.initials: H
authors.lastname: Kimura
authors.forename: Kengo
authors.initials: K
authors.lastname: Takeuchi
authors.forename: Manabu
authors.initials: M
authors.lastname: Soda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Mano
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Yasufuku
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Iizasa
mesh_terms: D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D044963:Biopsy, Fine-Needle / Q000379:methods*; D001999:Bronchoscopy / Q000379:methods*; D019160:Endosonography / Q000379:methods*; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D020794:Receptor Protein-Tyrosine Kinases
chemical_list: C522504:EML4-ALK fusion protein, human; D015514:Oncogene Proteins, Fusion; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases